|
BUB1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.977800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.537400E-01 |
| Normal-vs-Stage2 |
3.551200E-01 |
| Normal-vs-Stage3 |
1.713200E-01 |
| Normal-vs-Stage4 |
3.043800E-02 |
| Stage1-vs-Stage2 |
1.795140E-04 |
| Stage1-vs-Stage3 |
2.567400E-01 |
| Stage1-vs-Stage4 |
3.136300E-02 |
| Stage2-vs-Stage3 |
7.74390000000125E-05 |
| Stage2-vs-Stage4 |
8.19069999999922E-05 |
| Stage3-vs-Stage4 |
1.494200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.609000E-01 |
| Normal-vs-AfricanAmerican |
3.209800E-01 |
| Normal-vs-Asian |
4.881200E-01 |
| Caucasian-vs-AfricanAmerican |
8.785200E-01 |
| Caucasian-vs-Asian |
2.008800E-01 |
| AfricanAmerican-vs-Asian |
5.437400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.664200E-01 |
| Normal-vs-Female |
3.250200E-01 |
| Male-vs-Female |
6.773600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.903590E-01 |
| Normal-vs-Age(41-60Yrs) |
7.451400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.225600E-01 |
| Normal-vs-Age(81-100Yrs) |
7.617800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.143920E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.799000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.702810E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.498500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.973700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.819700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.398900E-03 |
| Classical-VS-Follicular |
2.87419976707781E-10 |
| Classical-VS-Other |
6.326000E-02 |
| Classical-VS-Normal |
1.484780E-01 |
| Tall-VS-Follicular |
1.82820000027561E-07 |
| Tall-VS-Other |
1.079850E-03 |
| Tall-VS-Normal |
3.119100E-03 |
| Follicular-VS-Other |
4.217000E-01 |
| Follicular-VS-Normal |
2.820200E-01 |
| Other-VS-Normal |
8.545200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.367200E-01 |
| Normal-vs-N1 |
2.240600E-01 |
| N0-vs-N1 |
8.952100E-02 |
|
|
